Biotech

All Articles

Lilly- backed weight management biotech documents IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...

Aelis' marijuana use medicine flunks period 2b, steering Indivior to review $100M alternative

.Aelis Farma's chances of securing an easy, good selection on a $one hundred thousand choice remitta...

ProKidney standstills phase 3 test not required for cell treatment approval

.ProKidney has stopped among a pair of phase 3 trials for its own cell treatment for renal health co...

Vaxcyte climbs on 'magnificent' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what professionals called "impressive" period 1/2 information for its own 31-valen...

Recursion's human brain disease test reveals scant proof of efficacy

.Recursion has actually stumbled via a very early examination of its tech-enabled strategy to drug d...

Acepodia, Pfizer click together for chemistry-based tissue treatment

.Phone it an instance of great chemical make up: Acepodia, a biotech based on Nobel Champion science...

Praxis epilepsy drug reduces confiscations in stage 2 trial

.Practice Accuracy Medicines has actually racked up an additional midphase gain in epilepsy this yea...

Three officers resign as Dyne messages blended records for DMD applicant

.After escaping a medical hold a number of years back, Dyne Therapy has actually shown brand-new per...

Arrowhead fires off phase 3 information in uncommon metabolic illness before market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its own give before a possible face-off with Ionis,...

Pfizer, Valneva reveal lyme disease try successful for 2nd booster

.Pfizer and Valneva might possess concerning pair of additional years to hang around just before the...